1. Home
  2. RNXT vs ATER Comparison

RNXT vs ATER Comparison

Compare RNXT & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ATER
  • Stock Information
  • Founded
  • RNXT 2012
  • ATER 2014
  • Country
  • RNXT United States
  • ATER United States
  • Employees
  • RNXT N/A
  • ATER N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • RNXT Health Care
  • ATER Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • ATER Nasdaq
  • Market Cap
  • RNXT 21.6M
  • ATER 25.8M
  • IPO Year
  • RNXT 2021
  • ATER N/A
  • Fundamental
  • Price
  • RNXT $1.08
  • ATER $2.79
  • Analyst Decision
  • RNXT Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • RNXT 3
  • ATER 1
  • Target Price
  • RNXT $6.13
  • ATER N/A
  • AVG Volume (30 Days)
  • RNXT 29.1K
  • ATER 46.3K
  • Earning Date
  • RNXT 11-13-2024
  • ATER 11-11-2024
  • Dividend Yield
  • RNXT N/A
  • ATER N/A
  • EPS Growth
  • RNXT N/A
  • ATER N/A
  • EPS
  • RNXT N/A
  • ATER N/A
  • Revenue
  • RNXT N/A
  • ATER $107,193,000.00
  • Revenue This Year
  • RNXT N/A
  • ATER N/A
  • Revenue Next Year
  • RNXT N/A
  • ATER $5.45
  • P/E Ratio
  • RNXT N/A
  • ATER N/A
  • Revenue Growth
  • RNXT N/A
  • ATER N/A
  • 52 Week Low
  • RNXT $0.53
  • ATER $0.23
  • 52 Week High
  • RNXT $2.35
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 57.50
  • ATER 45.44
  • Support Level
  • RNXT $1.04
  • ATER $2.85
  • Resistance Level
  • RNXT $1.05
  • ATER $3.10
  • Average True Range (ATR)
  • RNXT 0.07
  • ATER 0.17
  • MACD
  • RNXT 0.01
  • ATER 0.01
  • Stochastic Oscillator
  • RNXT 71.43
  • ATER 34.88

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: